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OBJECTIVES: This pilot study was designed to utilize stroke volume variation and cardiac index to ensure fluid
optimization during one-lung ventilation in patients undergoing thoracoscopic lobectomies.
METHODS: Eighty patients undergoing thoracoscopic lobectomy were randomized into either a goal-directed
therapy group or a control group. In the goal-directed therapy group, the stroke volume variation was
controlled at 10%¡1%, and the cardiac index was controlled at a minimum of 2.5 L.min-1.m-2. In the control
group, the MAP was maintained at between 65 mm Hg and 90 mm Hg, heart rate was maintained at between
60 BPM and 100 BPM, and urinary output was greater than 0.5 mL/kg-1/h-1. The hemodynamic variables, arterial
blood gas analyses, total administered fluid volume and side effects were recorded.
RESULTS: The PaO2/FiO2-ratio before the end of one-lung ventilation in the goal-directed therapy group was
significantly higher than that of the control group, but there were no differences between the goal-directed
therapy group and the control group for the PaO2/FiO2-ratio or other arterial blood gas analysis indices prior to
anesthesia. The extubation time was significantly earlier in the goal-directed therapy group, but there was no
difference in the length of hospital stay. Patients in the control group had greater urine volumes, and they
were given greater colloid and overall fluid volumes. Nausea and vomiting were significantly reduced in the
goal-directed therapy group.
CONCLUSION: The results of this study demonstrated that an optimization protocol, based on stroke volume
variation and cardiac index obtained with a FloTrac/Vigileo device, increased the PaO2/FiO2-ratio and reduced
the overall fluid volume, intubation time and postoperative complications (nausea and vomiting) in thoracic
surgery patients requiring one-lung ventilation.
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& INTRODUCTION
Perioperative goal-directed fluid therapy (GDT) is a
cornerstone of tissue perfusion and oxygenation, and it can
improve surgical outcomes. Optimal perioperative fluid
management is essential for reducing postoperative compli-
cations and mortality (1,2) rates. Surgical patients are more
likely to have serious complications and die if they have
limited physiologic reserves. Proper fluid administration can
reduce the stress response to surgical trauma and, thus,
support recovery, particularly in cardiothoracic surgery (3-5).
Fluid management in thoracic surgery is of particular
importance because of the influence of one-lung ventilation
(OLV). It has been reported that OLV can be a cause of
postoperative pulmonary edema (6,7). Edema formation
after OLV has been attributed to oxidative stress during and
immediately following OLV during reexpansion of the
deflated lung after conventional ventilation has been
reestablished (8,9). Therefore, OLV might act as an addi-
tional factor in aggravating perioperative pulmonary fluid
overload. Lung lobectomy also leads to an increase in
pulmonary proinflammatory cytokines and local edema.
A new stroke volume variation (SVV) and cardiac output
monitoring device, the Vigileo-FloTrac system (Edwards
Lifescience, Irvine, CA, USA), is based on arterial pulse contour
and does not require external calibration, thermodilution or
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dye dilution; therefore, it offers the possibility of almost beat-to-
beat measurements of cardiac output and SVV. The accuracy of
this device in assessing SVV and cardiac output has been tested
in numerous settings with varying results (10-19). Moreover,
the past limitations of SVV use, such as open chest, OLV and
arrhythmia, have been relaxed as the result of further
investigations (20-22).
In recent years, GDT, based on SVV derived from the
FloTrac system, has been used in many types of surgery to
improve postoperative outcomes (23-25). However, SVV
should be interpreted with caution. Under stable mechan-
ical ventilation, SVV is a marker of position on the Frank-
Starling curve and not an indicator of blood volume status
or of cardiac preload. The slope of the Frank-Starling curve
differs among patients depending on cardiac contractility:
the slope decreases in patients with decreased cardiac
contractility and increases in those with increased cardiac
contractility. Therefore, minimizing SVV by volume loading
can cause overhydration in patients with increased cardiac
contractility and occult hypovolemia in those with
decreased cardiac contractility (26). GDT based on SVV
can improve postoperative outcomes when the other
hemodynamic parameters, such as cardiac output and mean
arterial pressure, are also considered. We agree with other
authors’ findings that GDT based simply on stroke volume
optimization does not confer any additional benefits over
conventional liberal fluid therapy. However, GDT based on
a multiparametric approach could improve postoperative
outcomes because every hemodynamic variable has limita-
tions and interferes with other variables (27). This pilot
study was designed to utilize the SVV and cardiac indices
([CIs], cardiac output/body surface area) to ensure fluid
optimization during one-lung ventilation in patients under-
going thoracoscopic lobectomy.
& MATERIALS AND METHODS
We obtained institutional ethics committee approval from
the First Affiliated Hospital College of Medicine (Zhejiang
University) and written informed consent from the study
participants. Eighty patients satisfied the following inclu-
sion criteria and were enrolled in our study: age 18–60 years
old; American Society of Anesthesiologists physical status I–
II; and sinus rhythm. The exclusion criteria included risk of
hepatic/renal/cardiac dysfunction, severe obesity (body
mass index .35), severe aortic regurgitation, frequent
ventricular extrasystoles and one-lung ventilation time less
than 1 hour. All of the patients underwent thoracoscopic
lobectomy during one-lung ventilation. This prospective,
randomized trial was performed in a university-affiliated
hospital. The 80 patients were randomized preoperatively,
using a closed envelope system, into either the GDT group
or the control group. In the GDT group, SVV was controlled
at 10%¡1%, and CI was controlled at minimum of
2.5 L?min-1?m-2. In the control group, the mean arterial
pressure was maintained at between 65 mm Hg and 90 mm
Hg, heart rate was maintained at between 60 BPM
and 100 BPM, and urinary output was greater than
0.5 mL/kg-1/h-1. The monitoring included invasive arterial
pressure, electrocardiography, percutaneous oxygen satura-
tion and end-tidal carbon dioxide. Before anesthesia induc-
tion, a 20 G arterial line was inserted into the radial artery of
the non-dominant forearm, and baseline measurements and
blood were obtained for the laboratory tests. The optimal
pressure signal damping was assessed using a flush test
before the first measurements. SVV, CI, cardiac output,
stoke volume and stroke volume index were measured by
using the Vigileo-FloTrac system. General anesthesia was
induced with 0.7 mg/kg sufentanil, 2.5 mg/kg propofol and
0.15 mg/kg vecuronium. After anesthesia induction, a left-
sided double-lumen tube (Broncho-cath, Tyco Healthcare,
Argyle, Mansfield, MA, USA) was inserted, and each
patient was adjusted using a fiberoptic bronchoscope.
Anesthesia was maintained with 1.0–1.5% sevoflurane,
and the depth of anesthesia was maintained at 35–50 using
a bispectral index monitor (v. 4.0; Aspect Medical System,
Natick, MA, USA). The intraoperative inspired O2 concen-
tration (FiO2) was 100%. Additional sufentanil and vecur-
onium were administered as needed for further relaxation.
OLV was started with a ventilatory volume of 8 mL/kg and
positive end-expiratory pressure of 5 cm H2O, and either
the ventilation rate was 12 breaths/minute or it was
adjusted to maintain an arterial partial pressure of carbon
dioxide between 36 mm Hg and 44 mm Hg. The inspira-
tory-expiratory ratio was 1:2. The details of the modified
hemodynamic monitoring protocols for the GDT group are
summarized in Figure 1. Intraoperative basal fluid replace-
ment was realized in both groups with continuous infusion
of 8 mL/kg/hr of crystalloid solution. When the SVV was
greater than 11%, volume optimization was achieved by
administering a 50 mL bolus of colloid solution (Voluven
130/0.4 6%; Fresenius Kabi AG, Bad Homburg, Germany)
every minute until a stable SVV value of #9% was reached
for 2 minutes. The total administered crystalloid and colloid
volume were recorded for each patient. When the mean
arterial pressure dropped below 60 mm Hg despite fluid
resuscitation or during sudden blood loss, continuous
phenylephrine administration of 2 mg/min was initiated.
An infusion of dobutamine 2–5 mg/min/kg was started to
maintain the CI between 2.5 L/min/m2 and 4 l/min/m2
under low cardiac output state conditions (CI less than
2.5 l/min/m2). Ephedrine boluses of 5–15 mg were allowed
in addition to colloid infusion to treat a systolic arterial
pressure below 90 mm Hg or a mean arterial pressure less
than 65 mm Hg (e.g., during clamp release, sudden large
blood loss, etc.). The goal was to maintain the mean arterial
pressure above 70 mm Hg. These episodes were recorded as
hypotensive events and were submitted to analysis. After
extubation, SVV-guided fluid management was discontin-
ued because SVV is not validated for use during sponta-
neous breathing. In the control group, the anesthesiologist
was free to administer additional fluids (both crystalloids
and colloids) or to use vasoactive substances to maintain the
blood pressure, diuresis and heart rate within normal
ranges (mean arterial pressure .65 mm Hg, heart rate 60–
100 BPM, urine output .0.5 mL/kg/h). In both groups,
baseline hemodynamic measurements and arterial blood
gas analyses were performed before inducing anesthesia
(T1) and 10 minutes before the termination of OLV (T2).
Side effects (nausea and vomiting) were recorded in both
groups for 24 h after the end of surgery. Blood loss was
mitigated with fluids and a hemoglobin value less than
8 mg/dL-1 was considered to be a trigger for the transfusion
of packed red blood cells.
Statistical analysis
Patient data were collected and are presented as the means
¡ standard deviations, medians (interquartile ranges) and
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direct counts, as appropriate. For a test of normal distribu-
tion, the Kolmogorov-Smirnov test was applied. Continuous
data with normal distribution were tested with paired or
unpaired t-tests. Non-normally distributed data were sub-
jected to the Mann-Whitney U-test and Wilcoxon’s rank-sum
test for unpaired and paired results, respectively. Changes in
the time-dependent variables were measured using analysis
of variance on repeated measurements or Friedman’s test.
Categorical data were tested using the chi-square test and the
chi-square test for trends. The data were analyzed using the
Statistical Package for the Social Sciences (SPSS, version 15.0)
for WindowsTM, and p,0.05 was considered statistically
significant.
Ethics
Study approval was obtained from the Ethics Committee
of Zhejiang University (China).
& RESULTS
The patients’ characteristic data were similar between the
two groups (Table 1). Furthermore, no derangements in
metabolic parameters were found in either group. The
PaO2/FiO2-ratio before the end of OLV in the GDT group
was significantly higher than that in the control group, but
there was no difference between the GDT group and the
control group for the PaO2/FiO2-ratio or other arterial blood
gas analysis indices prior to anesthesia (Table 2). The
extubation time was significantly earlier in the GDT group,
but there was no difference in the length of hospital stay.
The patients in the control group had greater urine volumes
Figure 1 - Fluid management protocol based on SVV and CI (CI, cardiac index; SVV, stroke volume variation; PEEP, positive end-
expiratory pressure; VT, tidal volume; FiO2, fraction of inspired oxygen).
Table 1 - Demographic characteristics and laboratory
examinations.
Control group (n=30) GDT group (n=30)
Age (yr) 61.0¡8.7 59.9¡8.9
Sex (F/M) 14/16 12/18
Height (cm) 162¡5 162¡5
Weight (kg) 67¡9.7 71¡10.3
Heart rate (beats/min) 74¡3 76¡4
Systolic pressure 109.0¡28 106.6¡24
Diastolic pressure 62.0¡14.8 59.9¡11.4
MAP (mm Hg) 79.1¡19.2 74.8¡17.6
GPT (IU/L) 25.83¡8.15 23.31¡6.53
GOT (U/L) 21.82¡7.92 22.15¡9.26
Creatinine 63¡11 80¡15
Predicted FEV1% 86.5¡11.4 83.96¡8.7
The data are the means ¡ standard deviation. GPT: glutamic-pyruvic
transaminase. GOT: aspartate amino-transferase. FEV1: Forced expiratory
volume in one second.
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and were given greater colloid and overall fluid volumes.
Nausea and vomiting were significantly reduced in the GDT
group (Table 3). Dobutamine was used in 5 patients from
the GDT group when the CI was ,2.5 l/min/m2; therefore,
the ephedrine usage time in the GDT group was less than
that in the control group.
& DISCUSSION
To our knowledge, this is the first study using the Vigileo-
FloTrac monitor in the perioperative setting to guide fluid
management, with CI and SVV limited to small ranges
instead of using only the top limit value.
The present study showed that in patients undergoing
OLV, the PaO2/FiO2-ratio before the end of OLV in the GDT
group was significantly higher than that in the control
group. Extubation time was significantly earlier than in the
GDT group, which also had a reduced intubation time. The
control group patients had greater urine volumes and were
administered greater colloid and overall fluid volumes. That
is, fluid management guided by SVV and CI could reduce
pulmonary fluid overload and improve pulmonary oxygen
exchange, rather than destabilize the hemodynamics. The
combination of SVV and CI can be practically applies in
patients undergoing OLV, but the disturbing data on
arrhythmias, posture changes and artery sensor occlusion
should be excluded.
Our results were somewhat similar to those of Haas et al.
(24), who showed that SVV-guided fluid management
during lateral thoracotomy and OLV did not result in
pulmonary fluid overload. Although oxygenation was
reduced, pulmonary function remained within a clinically
acceptable range. Our experimental design was different
from that of the Haas et al. study in that their study was not
designed to demonstrate the clinical advantage of SVV-
guided fluid management compared to a control group.
Several indices, including fluid administration, were com-
pared between lung surgery and esophagectomy surgery
patients. Therefore, the results of Haas et al. must be
interpreted with caution. In addition, although they
monitored SVV, pulse index and continuous cardiac output,
Haas et al. did not combine SVV with other cardiac function
monitoring indices, such as cardiac index and cardiac
output.
In conventional clinical settings, hemodynamic variables,
such as heart rate, mean arterial pressure and central
venous pressure, are controlled by fluid therapy, blood
transfusions and vasopressor administration. However,
intraoperative hypovolemia is common and can be a potent
cause of organ dysfunction and increased postoperative
morbidity and mortality. Therefore, dynamic parameters,
such as arterial pulse pressure variation and SVV, have been
identified as the best indicators in mechanically ventilated
patients. Pulse pressure variation and SVV should be
interpreted with caution; however, under stable mechanical
ventilation, pulse pressure variation and SVV are only
markers of the position on the Frank-Starling curve and are
not indicators of blood volume status or markers of cardiac
preload. When not considering cardiac output maximiza-
tion as a target, fluid responsiveness does not indicate
whether fluids are needed. Patients should not receive
fluids only because of a high SVV value. A clinical approach
is needed to diagnose those patients presenting with
circulatory failure who would benefit from increasing stroke
volume. Most of these studies have used colloid titration to
increase cardiac output by bringing patients to the plateau
of the Frank-Starling curve (achieved when cardiac output
no longer increases after fluid challenge). Such cardiac
output maximization can be attained using cardiac output
monitoring or SVV or its surrogates (cardiac output
maximization is achieved by minimizing SVV or its
surrogates).
Regarding normal hemodynamics, the GDT group was
able to control the preload accurately. After the CI
decreased with the arterial blood pressure decline, we first
treated with dobutamine and then using the SVV target
value as a fluid infusion guide. Because the CI decrease
caused a cardiac function curve slope reduction, the mean
SVV values increased, but the patients were unsuitable for
fluid replacement (Figure 2), which is a key treatment for
improving cardiac function and avoiding fluid overload. In
Table 2 - Arterial blood gas analysis.
Control group (n =30) GDT group (n=30)
T1 T2 T1 T2
PH 7.44 (0.03) 7.33 (0.11) 7.40 (0.03) 7.43 (0.02)
PO2 81 (9) 241.9 (60.1) 86.0 (10) 334.5 (87.3)*
PaO2/
FiO2
385.7 (44.2) 241.9 (60.1) 409.5 (51.7) 334.5 (87.3)*
PCO2 38.5 (3.9) 41.88 (6.1) 37.8 (3.2) 41.2 (4.6)
HCO3 25.8 (1.67) 27.34 (1.53) 26.0 (1.73) 26.9 (1.84)
Hb 13.26 (1.05) 11.74 (1.11) 12.89 (1.26) 13.01 (1.32)
Lac 1.77¡0.8 1.79¡0.62 1.86¡0.66 1.82¡0.61
K 3.9 (0.5) 4.0 (0.4) 3.8 (0.5) 4.2 (1.2)
Na 136.3 (5.2) 139.9 (2.2) 137.1 (5.1) 135.4 (7.3)
Glu 5.32 (0.91) 5.63 (0.52) 5.81 (1.69) 6.09 (2.01)
The data are the totals (percentages) or means ¡ standard deviation.
*p,0.05 compared with 0.05% within groups. T1: before induction, air
inhaled. T2: at the end of one-lung ventilation. Fraction of inspired
oxygen: 100%.
Table 3 - Perioperative period data.
Control group (n=30) GDT group (n=30)
Duration of anesthesia (min) 117¡44 123¡48
Extubation time (min) 25¡12 6¡3*
Urinary output (mlNkg-1Nh-1) 2.2¡1.1 0.7¡0.3*
Blood loss (ml) 20¡5 218
Crystalloids (ml) 715¡120 625¡100
Colloids (ml) 670¡105 360¡85*
Total volume infused 1,385¡350 985¡135*
MAP (mm Hg) 80.6¡16.1 74.5¡18.3
Heart rate (bpm) 69¡15 75¡18
Dobutamine (case) 0 5*
Ephedrine (case) 9 3*
Length of hospital stay 5 4.5
Complications until hospital discharge
Re-intubation 0 0
Nausea and vomiting 12 6*
No defecation .2 days 0 0
Acute renal failure 0 0
Bronchial fistula 0 0
Re-operation for bleeding 0 0
Atelectasis 0 0
Pulmonary infection 4 3
The data are the totals (percentage) or means¡SD. *p,0.05 compared
with 0.05% within groups.
The means of the values were taken automatically every 5 minutes.
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our study, when the CI value was in the normal range, the
SVV value guided fluid infusion. If the CI value was less
than the normal range, we first corrected the CI values to
normal. We speculated that fluid management guided by
SVV and CI would reduce the overall fluid infusion
perioperatively. Our results were consistent with this
hypothesis. The volume of colloids and total volume infused
were lower in the GDT group than in the control group.
Each patient has an individual Frank-Starling curve;
therefore, in different types of operations or patient
situations, the corresponding cutoff values are different.
The optimal cut-off value for SVV is still uncertain in
different clinical scenarios. A study of living donor right
hepatectomy patients proposed that the optimal cutoff value
for SVV predicting blood loss of 700 mL was 6% (15). In
septic shock patients, the optimal threshold value for
distinguishing between responders and nonresponders
was 10% for SVV (28). Wu et al. found that a 14% supine
SVV predicted a decline in CI (20). These inconclusive
results show that further evaluation of dynamic variables is
needed, and the results of protocols based on SVV only
should be viewed cautiously. We used the 10%¡1%
threshold scope proposed by Suehiro (12), which was the
best available recommended value for the Vigileo-FloTrac at
the time that our protocol was prepared. A sustained
change in SVV greater than 11% or less than 9% for a period
of 3 minutes was required to start an intervention, to
exclude possible bias because of surgical manipulations or
other influences.
In this study, an interesting phenomenon occurred. In the
experimental group, it was difficult to maintain the SVV at
15%. After lateral positioning and OLV, the SVV value was
nearly 15%; therefore, a small amount of fluid caused the
SVV value to drop to less than 15%. Moreover, after the SVV
value was less than 15%, it was difficult to raise it. The cause
of this phenomenon was unclear.
Although most investigations have shown that goal-
directed fluid therapy can effectively improve patient
outcomes, it remains undetermined whether greater fluid
infusion guided by GDT is helpful. Lopes et al. (4)
demonstrated that the GDT group received more fluid than
the control group. The control group received fluid
intraoperatively at the discretion of the anesthetist, accord-
ing to the protocol proposed by Kobayashi et al. (4). Further
studies by Benes et al. (22) and Mayer et al. (23) both
showed that the SVV-guided group received significantly
larger volumes of colloid infusions, but the volumes of
infused crystalloids and the amounts of blood products and
blood loss did not differ between the groups.
However, a case series of laparoscopic adrenalectomies in
patients with pheochromocytoma demonstrated that both
total infusion volume and urine output were significantly
higher in the control group compared to the SVV-guided
group (29). Total blood loss was similar between the two
groups. The values of the net fluid balance divided by body
weight and of the total anesthesia period were significantly
lower in the SVV-guided group compared with the control
group. These data suggest that SVV monitoring is helpful
for estimating the optimal volume for fluid supplementa-
tion, and it could prevent excessive fluid infusion during
surgical procedures. The difference between these findings
might have resulted from two causes: first, the control
group received fluids at the discretion of the anesthetist,
resulting in significant variation; second, Isosu et al. omitted
target SVV values less than 10% and treated SVV values
between 1% and 10% identically, thereby causing an
obvious distinction in the amount of fluid infusion. In our
study, we paid attention to these differences and improved
the clinical protocol; therefore, the total amount of fluid
infusion in the SVV-guided group was lower than that in
the control group.
There were some possible limitations of this study worth
noting. First, we should have designed another group in
which we did not use SVV+CI, but only SVV, to guide fluid
management. Second, we ignored the timing of the fluid
administration, but Noblett et al. (30) indicated that the
timing of fluid administration might be more critical than
the volume of fluid administered. Third, our patients
underwent thoracoscopic lobectomy operations with OLV;
therefore, our results might not be applicable to other
patient groups undergoing other procedures. Fourth,
different types of lobectomy should be studied because of
their correlations to extubation times.
In conclusion, the results of this study demonstrated that
an optimization protocol, based on stroke volume variation
and cardiac index obtained with the FloTrac/Vigileo device,
increased the PaO2/FiO2-ratio and reduced the overall fluid
volume, intubation time and nausea and vomiting in
thoracic surgery patients requiring one-lung ventilation.
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